Infosys Limited (NYSE:INFY) Shares Acquired by Quadrant Capital Group LLC

Quadrant Capital Group LLC lifted its stake in shares of Infosys Limited (NYSE:INFY) by 1.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 102,086 shares of the technology company’s stock after acquiring an additional 1,313 shares during the quarter. Quadrant Capital Group LLC’s holdings in Infosys were worth $2,238,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of INFY. FMR LLC lifted its position in shares of Infosys by 77.8% during the 3rd quarter. FMR LLC now owns 170,704 shares of the technology company’s stock worth $3,802,000 after purchasing an additional 74,697 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Infosys by 62.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 514,838 shares of the technology company’s stock worth $11,465,000 after acquiring an additional 198,192 shares in the last quarter. Captrust Financial Advisors increased its holdings in shares of Infosys by 32.5% in the 3rd quarter. Captrust Financial Advisors now owns 21,718 shares of the technology company’s stock valued at $484,000 after acquiring an additional 5,325 shares during the last quarter. Benjamin Edwards Inc. acquired a new stake in shares of Infosys during the 3rd quarter worth about $232,000. Finally, Quantinno Capital Management LP raised its position in shares of Infosys by 47.4% during the 3rd quarter. Quantinno Capital Management LP now owns 86,985 shares of the technology company’s stock worth $1,937,000 after acquiring an additional 27,972 shares in the last quarter. Hedge funds and other institutional investors own 16.20% of the company’s stock.

Infosys Trading Down 4.5 %

NYSE INFY opened at $16.58 on Friday. The business’s 50 day moving average is $20.08 and its two-hundred day moving average is $21.57. The stock has a market capitalization of $68.66 billion, a price-to-earnings ratio of 20.98, a PEG ratio of 3.50 and a beta of 1.01. Infosys Limited has a 12-month low of $16.04 and a 12-month high of $23.63.

Infosys (NYSE:INFY) last announced its quarterly earnings data on Thursday, January 16th. The technology company reported $0.19 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.19. Infosys had a return on equity of 31.60% and a net margin of 17.28%. During the same quarter last year, the firm earned $0.18 EPS. Equities analysts forecast that Infosys Limited will post 0.74 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. HSBC upgraded shares of Infosys from a “hold” rating to a “buy” rating in a research note on Monday, December 9th. Hsbc Global Res upgraded shares of Infosys from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 9th. StockNews.com lowered shares of Infosys from a “buy” rating to a “hold” rating in a research note on Thursday, March 20th. Guggenheim reiterated a “neutral” rating on shares of Infosys in a research note on Friday, January 17th. Finally, CLSA upgraded Infosys from a “hold” rating to an “outperform” rating in a research report on Friday, March 7th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $19.70.

Infosys Company Profile

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication, Energy, Utilities, Resources, and Services, Manufacturing, Hi-Tech, Life Sciences, and All Other.